Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • allele (1)
  • and disease (1)
  • asians (4)
  • dementia (1)
  • female (1)
  • genotypes (3)
  • humans (1)
  • insomnia (9)
  • met met (1)
  • patients (2)
  • prion protein (3)
  • protein gene (1)
  • risk factor (2)
  • Val (3)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    Elucidate the core clinical and genetic characteristics and identify the phenotypic variation between different regions and genotypes of fatal familial insomnia (FFI). A worldwide large sample of FFI patients from our case series and literature review diagnosed by genetic testing were collected. The prevalence of clinical symptoms and genetic profile were obtained, and then the phenotypic comparison between Asians versus non-Asians and 129Met/Met versus 129Met/Val were conducted. In total, 131 cases were identified. The age of onset was 47.51±12.53 (range 17-76) years, 106 patients died and disease duration was 13.20±9.04 (range 2-48) months. Insomnia (87.0%) and rapidly progressive dementia (RPD; 83.2%) occurred with the highest frequency. Hypertension (33.6%) was considered to be an objective indicator of autonomic dysfunction. Genotype frequency at codon 129 was Met/Met (84.7%) and Met/Val (15.3%), and allele frequency was Met (92.4%) and Val (7.6%).129 Met was a risk factor (OR: 3.728, 95% CI: 2.194 to 6.333, p=0.000) for FFI in the non-Asian population. Comparison of Asians and non-Asians revealed clinical symptoms and genetic background to show some differences (p<0.05). In the comparison of 129 polymorphisms, a longer disease duration was found in the 129 MV group, with alleviation of some clinical symptoms (p<0.05). After considering survival probability, significant differences in survival time between genotypes remained (p<0.0001). Insomnia, RPD and hypertension are representative key clinical presentations of FFI. Phenotypic variations in genotypes and geographic regions were documented. Prion protein gene 129 Met was considered to be a risk factor for FFI in the non-Asian population, and 129 polymorphisms could modify survival duration. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

    Citation

    Jing Zhang, Min Chu, ZiChen Tian, KeXin Xie, Yue Cui, Li Liu, JiaLi Meng, HaiHan Yan, Yang-Mingyue Ji, Zhuyi Jiang, Tian-Xinyu Xia, Dongxin Wang, Xin Wang, Ye Zhao, Hong Ye, Junjie Li, Lin Wang, Liyong Wu. Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions. Journal of neurology, neurosurgery, and psychiatry. 2022 Mar;93(3):291-297

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34667102

    View Full Text